PACB Pacific Biosciences of California, Inc.
Healthcare$1.26+3.28%ClosedMarket Cap: $391.4M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$1.00
Target (Median)
$1.00
Target Range
$1.00 - $1.00
Upside from current price: -20.6%
Rating Distribution
0 Strong Buy4 Buy3 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Barclays | maintain | Underweight | Underweight |
| 2026-03-06 | Barclays | downgrade | Underweight | Equal Weight |
| 2025-12-15 | Barclays | maintain | Equal Weight | Equal Weight |
| 2025-11-11 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-11-10 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-08-11 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-06-25 | Barclays | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.47 | $192.6M | 4 |
| Sun Dec 31 | $-0.41 | $220.0M | 6 |
| Mon Dec 31 | $-0.34 | $246.7M | 4 |
| Tue Dec 31 | $-0.30 | $276.4M | 2 |